产品: SOX9 抗体
货号: AF6330
描述: Rabbit polyclonal antibody to SOX9
应用: WB IHC IF/ICC IP
反应: Human, Mouse, Rat, Monkey
预测: Pig, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus
分子量: 56kDa; 56kD(Calculated).
蛋白号: P48436
RRID: AB_2835186

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500, ip 1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human,Mouse,Rat,Monkey
预测:
Pig(100%), Horse(100%), Sheep(100%), Rabbit(100%), Dog(100%), Chicken(92%), Xenopus(92%)
克隆:
Polyclonal
特异性:
SOX9 Antibody detects endogenous levels of total SOX9.
RRID:
AB_2835186
引用格式: Affinity Biosciences Cat# AF6330, RRID:AB_2835186.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

campomelic dysplasia autosomal sex reversal; CMD 1; CMD1; CMPD 1; CMPD1; SOX 9; Sox9; SOX9_HUMAN; SRA 1; SRA1; SRXX2; SRXY10; SRY (sex determining region Y) box 9 (campomelic dysplasia autosomal; SRY (sex determining region Y) box 9; SRY (sex determining region Y)-box 9; SRY (sex-determining region Y)-box 9 protein; SRY related HMG box gene 9; Transcription factor SOX 9; Transcription factor SOX-9; transcription factor SOX9;

抗原和靶标

免疫原:
Uniprot:
基因/基因ID:
描述:
SOX9 Plays an important role in the normal skeletal development. May regulate the expression of other genes involved in chondrogenesis by acting as a transcription factor for these genes. Defects in SOX9 are the cause of campomelic dysplasia (CMD1).
序列:
MNLLDPFMKMTDEQEKGLSGAPSPTMSEDSAGSPCPSGSGSDTENTRPQENTFPKGEPDLKKESEEDKFPVCIREAVSQVLKGYDWTLVPMPVRVNGSSKNKPHVKRPMNAFMVWAQAARRKLADQYPHLHNAELSKTLGKLWRLLNESEKRPFVEEAERLRVQHKKDHPDYKYQPRRRKSVKNGQAEAEEATEQTHISPNAIFKALQADSPHSSSGMSEVHSPGEHSGQSQGPPTPPTTPKTDVQPGKADLKREGRPLPEGGRQPPIDFRDVDIGELSSDVISNIETFDVNEFDQYLPPNGHPGVPATHGQVTYTGSYGISSTAATPASAGHVWMSKQQAPPPPPQQPPQAPPAPQAPPQPQAAPPQQPAAPPQQPQAHTLTTLSSEPGQSQRTHIKTEQLSPSHYSEQQQHSPQQIAYSPFNLPHYSPSYPPITRSQYDYTDHQNSSSYYSHAAGQGTGLYSTFTYMNPAQRPMYTPIADTSGVPSIPQTHSPQHWEQPVYTQLTRP

种属预测

种属预测:

score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。

Species
Results
Score
Pig
100
Horse
100
Sheep
100
Dog
100
Rabbit
100
Xenopus
92
Chicken
92
Bovine
0
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

翻译修饰 - P48436 作为底物

Site PTM Type Enzyme
T11 Phosphorylation
S30 Phosphorylation
T43 Phosphorylation
T46 Phosphorylation
K61 Acetylation
S64 Phosphorylation P17612 (PRKACA)
K68 Ubiquitination
S78 Phosphorylation
K82 Ubiquitination
K122 Ubiquitination
K137 Ubiquitination
K141 Acetylation
K141 Ubiquitination
Y172 Phosphorylation
K173 Ubiquitination
S181 Phosphorylation P17612 (PRKACA) , Q13237 (PRKG2) , Q13464 (ROCK1)
T196 Phosphorylation
S199 Phosphorylation
S211 Phosphorylation
S214 Phosphorylation
S223 Phosphorylation
T236 Phosphorylation
T239 Phosphorylation
T240 Phosphorylation
K249 Ubiquitination
K253 Acetylation
K398 Acetylation
S414 Phosphorylation
Y442 Phosphorylation

研究背景

功能:

Transcriptional regulator that plays a role in chondrocytes differentiation and skeletal development. Binds to the COL2A1 promoter and activates COL2A1 expression, as part of a complex with ZNF219 (By similarity).

翻译修饰:

Ubiquitinated. Ubiquitination leads to proteasomal degradation and is negatively regulated by DDRGK1.

细胞定位:

Nucleus.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
亚基结构:

Interacts (via C-terminus) with ZNF219. Interacts with DDRGK1.

研究领域

· Environmental Information Processing > Signal transduction > cAMP signaling pathway.   (View pathway)

文献引用

1). A lithium-containing biomaterial promotes chondrogenic differentiation of induced pluripotent stem cells with reducing hypertrophy. Stem Cell Research & Therapy (PubMed: 32085810) [IF=7.5]

Application: IF/ICC    Species: Human    Sample: iPSCs

Fig. 7 The chondrogenic differentiation of iPSCs with different Li+ ions concentration in 14 days. a Immunofluorescence of chondrocytes specified proteins (COL II, Aggrecan, and SOX9) and hypertrophic specified protein (COL X and MMP13). b The average fluorescence intensity of COL II, Aggrecan, SOX9, MMP13, and COL X proteins in each group, n = 5. c The relative genes expression of chondrogenic differentiation cultured with Li+ ions, n = 3. d The relative genes expression of hypertrophic differentiation cultured with Li+ ions, n = 3. Data presented as mean ± SEM. Scale bar = 200 μm. CTR: MCDM without any Li+ ions. *p < 0.05, **p < 0.01, ***p < 0.001

2). Asiatic acid attenuates hypertrophic and fibrotic differentiation of articular chondrocytes via AMPK/PI3K/AKT signaling pathway. ARTHRITIS RESEARCH & THERAPY (PubMed: 32398124) [IF=4.9]

3). Region-specific effects of blocking estrogen receptors on longitudinal bone growth. JOURNAL OF ENDOCRINOLOGY (PubMed: 34014834) [IF=4.0]

4). Ddit3 suppresses the differentiation of mouse chondroprogenitor cells. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (PubMed: 27845261) [IF=4.0]

Application: WB    Species: mouse    Sample:

Fig. 5. Effects of C/EBP and Sox9 on the differentiation of ATDC5. (a and d) Relative mRNA levels of Sox9 and C/EBP in three groups. (b and c) Detection and quantification of Sox9 by Western blot and image J. (e and f) Detection and quantification of C/EBP by Western blot and image J. All data were expressed as means ± SD. *p < 0.05, **p < 0.01, ***p < 0.0001, compared to scrambled group. t

5). Fatty acid binding protein 3 deficiency limits atherosclerosis development via macrophage foam cell formation inhibition. EXPERIMENTAL CELL RESEARCH (PubMed: 34370993) [IF=3.7]

Application: WB    Species: Mice    Sample: macrophages

Fig. 3. FABP3 knockdown reduced macrophage foam cell formation. Murine peritoneal macrophages were maintained in the special culture medium at 37 ◦C in a 5 % CO2 atmosphere. The cells were infected with lentivirus carrying shFABP3 or shRNA NC for 24 h and subsequently exposed with ox-LDL (50 μg/ml) for 24 h. (A) Representative Oil Red O-stained images of macrophages and quantification of the staining. (B) Immunoblots of SRA1, CD36, SRB1, ABCA1, and ABCG1 in macrophages. (C) Quantification of relative mRNA expression of SRA1, CD36, SRB1, ABCA1, and ABCG1. **p < 0.01 denote significant differences between the Control and the ox-LDL groups, &&p < 0.01 denote significant differences between the ox-LDL shRNA NC and ox-LDL + shFABP3 groups.

6). Impaired proliferation of growth plate chondrocytes in a model of osteogenesis imperfecta. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (PubMed: 35561582) [IF=3.1]

7). Effect of tissue expansion on chondrocyte sheets in cartilage composite reconstruction. American Journal of Translational Research (PubMed: 35035686) [IF=2.2]

Application: WB    Species: Rat    Sample:

Figure 8 Evaluation of protein expression and cartilage-related genes in the chondrocyte sheets cultured in vitro under static pressure and hypoxic conditions. (A) Protein expression of Aggrecan, COL II, Sox-9, and HIF-1α as determined using western blotting; β-actin was used as a loading control. The expression of Aggrecan (B), COL II (C), Sox-9 (D) and HIF1-α (E) genes was determined using real-time PCR. GAPDH was used as a housekeeping gene. Data are presented as the mean ± standard deviation (n=3), *P

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.